IP
NKTR icon

Intellectus Partners’s Nektar Therapeutics NKTR Stock Holding History

Intellectus Partners’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$377K Buy
+5,400
New +$395K 0.07% 230
2025
Q2 		– Sell
-667
Closed -$6.8K – 287
2025
Q1 		$6.8K Hold
667
– – ﹤0.01% 268
2024
Q4 		$9.3K Hold
667
– – ﹤0.01% 273
2024
Q3 		$13K Hold
667
– – ﹤0.01% 263
2024
Q2 		$12.4K Buy
+667
New +$14.1K ﹤0.01% 259

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Intellectus Partners's NKTR Position: Q2 2026 in Review

Intellectus Partners opened a new position in Nektar Therapeutics (NKTR) in Q2 2026: 5,400 shares worth $377K. The stake represents 0.07% of the portfolio and ranks #230 among its holdings. This is a return to the name: Intellectus Partners previously reported a position in NKTR as recently as Q1 2025.

Intellectus Partners first reported a position in NKTR in Q2 2024 and has held it in 5 quarters since. 240 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • Intellectus Partners held 5,400 shares of Nektar Therapeutics worth $377K as of Q2 2026.
  • Nektar Therapeutics was a new Intellectus Partners position in Q2 2026.
  • Nektar Therapeutics made up 0.07% of Intellectus Partners's portfolio in Q2 2026, its #230 holding.
  • Intellectus Partners first reported a position in Nektar Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Intellectus Partners's 13F filing for Q2 2026, filed 12 Aug 2026.